ANKURDRUGS

Members of the Exchange are hereby informed that trading in the equity shares of Ankur Drugs And Pharma Limited will be suspended w.e.f. September 11, 2013 (i.e. closing hours of trading on September 10, 2013) as the company has failed to respond to the notices of the Exchange for non-compliance with the provisions of listing agreement. It may also be noted that the Official Liquidator of Hon'ble High Court of Bombay, has informed the Exchange that, by an order dated 08-07-2013 passed by Hon'ble High Court of Bombay in C P No: 103 of 2012, Ankur Drugs And Pharma Limited shall be wound up a

Price movement : Significant price movement has been observed in Ankur Drugs And Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ankur Drugs And Pharma Limited has vide its letter inter-alia stated, "In this connection we have to advice that no activity influencing the price movement of scrip is taking place in the Company. The volatility in the movement of the scrip price is purely market driven and Company in nowhe

Price movement : Significant price movement has been observed in Ankur Drugs And Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ankur Drugs And Pharma Limited has vide its letter inter-alia stated, " The Company does not have any price sensitive information to disclose under Clause 36 of the listing agreement".